Deutsche Bank Ag\ Ani Pharmaceuticals Inc Transaction History
Deutsche Bank Ag\
- $287 Billion
- Q3 2025
A detailed history of Deutsche Bank Ag\ transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 252,568 shares of ANIP stock, worth $21.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
252,568
Previous 221,696
13.93%
Holding current value
$21.2 Million
Previous $14.5 Million
59.94%
% of portfolio
0.01%
Previous 0.01%
Shares
40 transactions
Others Institutions Holding ANIP
# of Institutions
284Shares Held
20.3MCall Options Held
30.6KPut Options Held
30.7K-
Black Rock Inc. New York, NY2.66MShares$223 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$107 Million0.0% of portfolio
-
State Street Corp Boston, MA712KShares$59.8 Million0.0% of portfolio
-
Global Alpha Capital Management Ltd.631KShares$53 Million3.26% of portfolio
-
Ubs Group Ag590KShares$49.6 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.46B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...